SRAM & MRAM Develop Healthcare Facilities in Kazakhstan
SRAM & MRAM group has been granted land in Kazakhstan for developing healthcare facilities, including a medical college, hospital, and luxury hotel.

Photograph: Danish Siddiqui/Reuters
Mumbai, Oct 24 (PTI) UK-based consultancy SRAM & MRAM group on Thursday said it has been granted a long-term lease of land by the Kazakhstan government for developing healthcare facilities.
The Kazakh government has officially granted the group a long-term lease on the land following the completion of all formalities, SRAM & MRAM group said in a statement.
Around 243 hectares have been allotted in Astana and 100 hectares in Almaty, it added.
The group has joined hands with Big B Corporation and KAZIND Medical Group of Kazakhstan to develop healthcare facilities in Kazakhstan. The partnership aims to develop a medical college, a multispeciality hospital with 1000 beds capacity and a luxury hotel.
The entities looks to establish the largest medical university in the region, along with a hospital, offering medical and paramedical education to international students, it added. PTI
The Kazakh government has officially granted the group a long-term lease on the land following the completion of all formalities, SRAM & MRAM group said in a statement.
Around 243 hectares have been allotted in Astana and 100 hectares in Almaty, it added.
The group has joined hands with Big B Corporation and KAZIND Medical Group of Kazakhstan to develop healthcare facilities in Kazakhstan. The partnership aims to develop a medical college, a multispeciality hospital with 1000 beds capacity and a luxury hotel.
The entities looks to establish the largest medical university in the region, along with a hospital, offering medical and paramedical education to international students, it added. PTI
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GMR-Airports
- 94.51 (+ 0.27)
- 53672515
- NHC-Foods
- 1.26 (+ 15.60)
- 49552538
- Vodafone-Idea
- 13.58 (+ 0.67)
- 38954318
- Pulsar-Intl
- 0.69 ( -4.17)
- 14324011
- Biogen-Pharmachem
- 0.37 ( -5.13)
- 10240228





